09.11.2018 Issue 418

Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Round-up
The Top Story in HEOR: Latest Headlines in HEOR:

AMCP Offers Free Webinar on Payer Dossiers

Friday, September 7

This Sept. 12 web event will capture the current state of payer perceptions regarding dossier timing, quality and use as well as future considerations for improving dossier relevancy and optimization of use.

Pressure Mounts for Pharma Over Transparency

Companies Work to Incorporate Blockchain Tech

Health Systems Partner to Manufacture Generic Drugs

Wearables Poised to be Boon for Clinical Research

Poll: Trump’s Pharma Shaming Not Likely to Reduce Drug Prices

ICER Report Assesses Drugs for Treatment of Opioid Use Disorder

Analyst: Insurance Strategy Pulls Down Drug Prices

Senator Wants Details on Trump’s Naloxone Plan

ISMPP Issues Call for Session Proposals for 2019 Meeting

Healthcare Software Product Manager

Health Economist

Lead Health Economist

Associate Director Health Economics

Associate Director Real World Evidence (RWE) and Epidemiology

Associate Director/ Director, Medical Affairs- HEOR

Watson Health - Outcomes Research Leader (HEOR)

Senior Research Analyst - HEOR

Industry Spotlight

Conferences Webinars
6th Annual Coupon and Copay
    September 12-13, Philadelphia, Pennsylvania

11th Product Selection and Pipeline Optimization for Generics
    September 12-13, Philadelphia, Pennsylvania

2018 Observation Patient Management Forum
    September 13-14, Orlando, Florida

5th Annual Predictive Analytics in Health Care Summit
    September 13-14, Boston, Massachusetts

4th World Congress on Health Economics
    September 13-14, Zurich, Switzerland

PROving Its Worth: How to Develop a PRO Strategy to Distinguish Your Product with Regulators and Payers
    September 12

Review and Approval of Scientific Publications: Processes, Practices and Execution
    September 12

Pre- and Post-Approval Dossiers: Making All Evidence Count
    September 12

Artificial Intelligence in Health Care: The Hope, the Hype, and the Real World Impacts
    September 13

Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Benchmarking Market Access Strategies for High-Cost Drugs, Biologics

Blockchain: Transformational Change for Pharma?

Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

HTA in Europe: Key Success Factors for Positive HTA Recommendations

Paying for Digital Health: Payer Insights

Benchmarking Pharma’s MSL Capabilities

Biosimilars: U.S. Payer Perspectives

Advancing Biosimilar Sustainability in Europe

A Holistic Approach to Payment Accuracy Helps Drive Cost Savings

Improving Patient Matching with a Simple Plug-In

Real-World Evidence in the Cloud: How Technology is Revealing the Big Picture in Pharma

How Payers Can Save an Average of $25,579 Per Patient by Eliminating Unwarranted, Non-Evidence-Based Cancer Treatment

ICER’s Reference Case for Economic Evaluations: Principles and Rationale

Special Thanks to Our Partners:
            Evidera   HealthCore     University of FL
      Xcenda  OM1    Parexel   Jefferson   Dymaxium
      Precision Xtract    Pharmerit    eMax Health   Sciformix
      Evidence Partners    ICON    Truven